Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery

Summary

The purpose of this study is to evaluate superior efficacy of DE-108 ophthalmic solution to that of Levofloxacin 0.5% ophthalmic solution as well as safety of the former used for perioperative bacteria eradication in patients who are scheduled for cataract surgery.

Timeline

Start

2015-09-21

Primary completion

2017-03-31

Completion

2017-03-31

Drugs

Indications